Nyxoah S.A. (NYXH) vs Voyager Therapeutics, Inc. (VYGR)
A side-by-side comparison of Nyxoah S.A. and Voyager Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NYXH
Nyxoah S.A.
$1.43HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VYGR
Voyager Therapeutics, Inc.
$2.46HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NYXH vs VYGR
growth of $100 · dividends reinvested · last 5yNYXH -94.1% (-43.3%/yr)VYGR -54.8% (-14.7%/yr)VYGR compounded faster over this window
Log scale — wide-divergence pair
NYXH VYGR
NYXH vs VYGR: by the numbers
- •VYGR is the larger company ($149M vs $143M market cap).
- •Both run net losses; VYGR's is the smaller (-312.63% vs -435.70% net margin).
- •NYXH grew revenue faster over the past five years (120.68% vs -23.59% CAGR).
Metrics side by side
Valuation
| Metric | NYXH | VYGR |
|---|---|---|
| P/S ratio | 5.46 | 4.31 |
| P/B ratio | 1.51 | 0.96 |
Profitability
| Metric | NYXH | VYGR |
|---|---|---|
| Gross margin | 63.13% | -227.62% |
| Operating margin | -827.76% | -326.56% |
| Net margin | -435.70% | -312.63% |
| ROE | -120.33% | -69.78% |
| ROIC | -61.13% | -64.72% |
Growth (annualized)
| Metric | NYXH | VYGR |
|---|---|---|
| Revenue CAGR (5Y) | 120.68% | -23.59% |
| Total return CAGR (5Y) | -45.84% | -0.08% |
Frequently asked
- Which has grown faster, NYXH or VYGR?
- Over the past five years, NYXH grew revenue faster — NYXH at a 120.68% CAGR versus VYGR at -23.59%.
- How have NYXH and VYGR total returns compared?
- Over the past 5 years, NYXH delivered -45.84% and VYGR delivered -0.08% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Nyxoah ROEVoyager Therapeutics ROENyxoah operating marginVoyager Therapeutics operating marginNyxoah revenue growthVoyager Therapeutics revenue growthNyxoah free cash flowVoyager Therapeutics free cash flow
Nyxoah & Voyager Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.